MD
Pediatrix Medical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Ample Liquidity
High Gross Profit Margin
Significant Net Income Growth
High Cash/net Profit Ratio
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MD
Pediatrix Medical Group, Inc.
The nation’s leading provider of highly specialized health care for women, children and babies
Healthcare Providers and Services
--
09/20/1995
New York Stock Exchange
6,455
12-31
Common stock
1301 Concord Terrace, Sunrise, Florida 33323
--
Pediatrix Medical Group, Inc., is a leading provider of physician services, principally in maternal, infant and pediatric care and anesthesia care. As of December 31, 2015, the company has 3,240 medical practitioners who provide professional maternal and child care for pregnant expectant mothers or mothers. The company has 1,150 affiliated doctors to participate in procedures such as surgery, as well as pain management to provide anesthesia care to patients. The company was founded in 1979 in Florida.
Earnings Call
Q1/2025
Estimate EPS0.24
Actual EPS0.33
Estimate Revenue451.44M
Actual Revenue458.36M
Pediatrix Medical's Q1 2025: Navigating Contradictions in Guidance, Payer Mix, and Hospital Subsidies
May 06,2025 07:30
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.42
Actual EPS0.53
Estimate Revenue464.37M
Actual Revenue468.84M
Pediatrix Medical Group's Q2 2025: Key Contradictions in Admin Fees, Growth Expectations, and Buyback Strategies
Aug 05,2025 11:04
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.47
Actual EPS0.67
Estimate Revenue476.44M
Actual Revenue493.00M
Pediatrix Medical Group's Q3 2025: Contradictions Emerge on Share Buybacks, Pricing Drivers, and Hospital Subsidies
Nov 03,2025 11:22
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
MD has released its 2025 Q3 earnings. EPS was reported at 0.67, versus the expected 0.47, beating expectations. The chart below visualizes how MD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MD has released its 2025 Q3 earnings report, with revenue of 492.88M, reflecting a YoY change of -3.58%, and net profit of 71.71M, showing a YoY change of 268.85%. The Sankey diagram below clearly presents MD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
